Interaction check not available yet — this product's ingredients haven't been matched to our database.
Dietary supplement

Omega 3 Ingredients & Drug Interactions

by Hero Nutritionals Yummi Bears

Omega 3 label
See full label image
Gummy Or Jelly Category: Fat/fatty Acid
Most serious interaction: Moderate
Clinical methodology reviewed by · Updated Sep 16, 2026 · Label data from the NIH DSLD
What is this page for?

First and foremost: checking Omega 3 against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.

Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy

The interaction bottom line Most serious interaction: Moderate

Omega 3 is a dietary supplement by Hero Nutritionals Yummi Bears with 1 active ingredient.Based on those ingredients, 375 medications have a known interaction with it, the most serious rated moderate. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

Jump to a section

Check Your Meds Against Omega 3 by Hero Nutritionals Yummi Bears

Ask about any prescription or over-the-counter medication and we check it for interactions with Omega 3 by Hero Nutritionals Yummi Bears — and tell you which ingredient is responsible.

Pharmacist-reviewed data Checks every ingredient Answer in seconds
Prefer a human? Send your question to our licensed pharmacists — free, answered by email within 24 hours.

HelloPharmacist Scorecard of Omega 3 by Hero Nutritionals Yummi Bears

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules · Last generated Jul 11, 2026

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 3 of its 3 active ingredients.
  • “Essential Fatty Acids” is listed as a grouped ingredient — the label gives one combined amount (148 mg) without saying how much of each component you get.
  • “organic Chia seed Oil” is listed as a grouped ingredient — the label gives one combined amount (216 mg) without saying how much of each component you get.

This gummy contains 3 active ingredients: Omega-3 (listed as Docosahexaenoic Acid or DHA), Omega-6, and Omega-9. Omega-3 is a long-chain fatty acid your body uses to support heart and brain function.

The other two are also essential fatty acids — fats your body needs but can't make on its own, so you have to get them from food or supplements. The gummy base includes natural cane sugar, organic tapioca syrup, pectin (a natural gelling agent), and flavoring.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use — see Docosahexaenoic Acid (dha)'s own graded uses on its monograph.

Why this rating?
  • The label markets this product for: healthy vision and brain function.
  • We looked for evidence on: Age-related cognitive decline, Age-related macular degeneration (AMD), Alzheimer disease, Cognitive function, Cognitive impairment, Diabetic retinopathy — and 4 related terms.
  • The closest evidence on file: Docosahexaenoic Acid (dha) is rated "Possibly Ineffective" for Age-related cognitive decline (Natural Medicines).
  • Also on file: Docosahexaenoic Acid (dha) is rated "Possibly Ineffective" for Alzheimer disease, Cognitive function.
  • Also on file: Docosahexaenoic Acid (dha) is rated "Insufficient Reliable Evidence To Rate" for Age-related macular degeneration (AMD), Cognitive impairment, Vascular dementia, Diabetic retinopathy.

For Omega-3 in this product, the evidence shows it's possibly effective for two conditions: preterm labor and high cholesterol (hyperlipidemia). However, the data we hold rates it possibly ineffective for cognitive function and ADHD, meaning the evidence doesn't support it for those uses.

The strength of the evidence is limited in both directions — there's some research behind each claim, but it's not conclusive.

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Omega-3 is generally well tolerated at typical supplement doses in adults. The most common side effects are belching, a fishy aftertaste, loose stools, and nausea — usually mild and temporary.

Rare serious side effects include a small increased risk of bleeding at very high doses. For pregnancy and breastfeeding, Omega-3 is rated likely safe, though the facts advise using it only under your doctor's guidance during pregnancy and choosing a purified, low-mercury source.

Omega-3 does pass into breast milk and is generally considered acceptable, but check with your doctor on the right dose and product quality.

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Docosahexaenoic Acid (dha).
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: anticoagulant / antiplatelet drugs; diabetes medications.
  • For scale: 375 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking this product, check with your pharmacist if you're on blood thinners or antiplatelet drugs (like warfarin or aspirin for clotting prevention), blood pressure medications, or diabetes medications — all are Moderate-severity interactions with the Omega-3 in this gummy.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. Moderate medication interactions have been identified, and safety information is well characterized.

This gummy works well if you're looking to support cholesterol levels or reduce preterm labor risk under medical supervision. If you take blood thinners, blood pressure medication, or diabetes drugs, you need to check with your pharmacist before starting — the Omega-3 here can interact with all three.

The product is generally well tolerated, but expect possible fishy aftertaste or loose stools.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 3 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Jun 16, 2022.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Omega 3, straight from the product label.

Brand Hero Nutritionals Yummi Bears
Net contents 90 Yummi Bear(s)
Market status On market
Date entered into DSLD Jun 16, 2022
DSLD ID 268232
Product type Fat/fatty Acid
Supplement form Gummy Or Jelly
Dietary claims / uses Nutrient, All Other, Structure/Function
Intended target group(s) Vegan, Vegetarian, Children (All), No Allergies, Gluten Free, Dairy Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Omega 3 by Hero Nutritionals Yummi Bears, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
4 Bear(s)
Maximum serving Sizes:
4 Bear(s)
Servings per container
22
IngredientAmount% DV
Calories40 Calorie(s)--
Total Carbohydrate8 Gram(s)3%
Sugars7 Gram(s)--
Essential Fatty Acids148 mg--
Omega-632 mg--
Omega-912 mg--
organic Chia seed Oil216 mg--
Omega-3104 mg--

Other ingredients: natural Cane Sugar, organic Tapioca Syrup, Pectin, Citric Acid, natural Cranberry-Orange flavor, Sodium Citrate, Purple Carrot juice concentrate

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

New look!

Actual size and serving:

Gummy product may settle over time.

Questions or comments? 800.500.HERO (4376) 8am-4pm, M-F, PST heronutritionals.com

Our passion continues in providing essential nutrients for the whole family, with Yummi Slices Adult Gummy Vitamins - a wide range of nutritional support for adults, in delicious, easy to take gummies.

Brand IP Statement(s)

The Original Gummy Vitamin

Pure love deserves pure nutrition The original gummy vitamin for over 20 years

Formulation

For healthy vision and brain function

Vegetarian approved Vegan

Non GMO Allergen free Gluten free Dairy free

Yummi Bears Vegetarian Omega 3 delivers essential omega fatty acids from chia seed oil that's fish-free, mercury-free, GMO free and still delightfully yummi.

Non GMO no genetically modified ingredients

Brain supports brain power Vision for eye health

Free of: GMOs, gluten, gelatin, yeast, wheat, dairy, eggs, soy, tree nuts, peanuts, shellfish, fish, artificial flavors, artificial colors and artificial preservatives.

Product appearance may change over time due to natural color. This does not alter the potency of the product.

Manufactured in the USA in our state-of-the-art certified organic facility.

Yummi Bears and Yummi Slices gummy vitamins are made in our state-of-the-art, certified organic facility in California, so you can be assured you are getting the best quality.

FDA Disclaimer Statement

Dietary Supplement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Formula

Plant-based omegas at your service. Yummi Bears Vegetarian Omega 3 delivers essential omega fatty acids from chia seed oil that's fish-free, mercury-free, GMO free and still delightfully yummi.

104mg omega 3 high potency 32mg omega 6 high potency Vegetarian fruit pectin base

For over 20 years we've been making Yummi Bears - The Original Gummy Vitamin formulated just for kids.

And because you care about what goes into your kids, we care about what goes into our gummies: natural fruit flavors, colors and sweeteners - plus they're non-GMO, allergen and gluten free.

Suggested/Recommended/Usage/Directions

Suggested Use: As a dietary supplement, give each child four (4) bears per day.

Precautions

Oxygen-absorbing packet included inside bottle to ensure freshness - do not eat.

Keep out of reach of children.

Storage

Store in a cool, dry place. Do not use if safety seal is broken. Keep sealed for freshness. Refrigerate after opening.

Is this label outdated? Report a formula or label change and our pharmacy team will review it.

See for yourself

Omega 3 by Hero Nutritionals Yummi Bears label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

Omega 3 label

Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.

View the full label (PDF)
What’s inside

The Ingredients in Omega 3 by Hero Nutritionals Yummi Bears

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size4 Bear(s) Dosage formGummy Or Jelly Servings per container22 Amounts shown are per serving.

Organic Chia seed Oil

216 mg per serving
  • › Essential Fatty Acids

Other (inactive) ingredients: Natural Cane Sugar, Organic Tapioca Syrup, Pectin, Citric Acid, Natural Cranberry-Orange flavor, Sodium Citrate, Purple Carrot juice concentrate. These complete the product’s ingredient list but are not active constituents.

Interaction report

Omega 3 by Hero Nutritionals Yummi Bears Drug Interactions

Want to check YOUR meds against Omega 3?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

 Go to the checker
375Drugs
375 Moderate

Ingredients driving the most interactions

Individual Drug Interactions

The ingredients in Omega 3 interact with 375 drugs. Click any drug to see the details.

0 of the 1 ingredient in Omega 3 interact with drugs. Each result below shows which ingredient is responsible.

Each ingredient & the kinds of drugs it affects

For each ingredient in Omega 3 with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

The maker

Brand information

Manufacturer and brand details for Omega 3, from the product label.

Hero Nutritionals Yummi Bears

See all Hero Nutritionals Yummi Bears products
Name
Hero Nutritionals, Inc.
City
Santa Ana
State
CA
ZipCode
92705
Phone Number
800.500.4376
Web Address
www.heronutritionals.com
Pharmacist Counseling Corner

Omega 3 by Hero Nutritionals Yummi Bears: Common Questions

Does Omega 3 by Hero Nutritionals Yummi Bears interact with any medications?
Yes. Based on its ingredients, Omega 3 has a known interaction with 375 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Omega 3 contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Will this give me fishy burps?
Possibly. Belching and a fishy aftertaste are the most common side effects reported with Omega-3 supplements. Loose stools and nausea can also happen, but they're usually mild. Taking it with food may help.
Is this safe during pregnancy or breastfeeding?
Omega-3 is rated likely safe in both pregnancy and breastfeeding. During pregnancy, use only under your doctor's guidance and pick a purified, low-mercury source. While breastfeeding, the Omega-3 passes into your milk — check with your doctor on the right dose for you and your baby.
Does this actually help with ADHD or brain function?
The evidence doesn't support it for either. Research rates Omega-3 as possibly ineffective for cognitive function and ADHD, so this gummy wouldn't be the right choice if that's why you're considering it.
Can I take this if I'm on a blood thinner?
Not without talking to your pharmacist first. Omega-3 may theoretically increase bleeding risk when combined with blood thinners or antiplatelet drugs — it's a Moderate-severity interaction. Your pharmacist can help you figure out if it's safe for your specific situation.
What are the inactive ingredients?
The gummy base includes natural cane sugar, organic tapioca syrup, pectin, citric acid, natural cranberry-orange flavor, sodium citrate, and purple carrot juice concentrate for color.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Omega 3 is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Omega 3 label
Sources

Sources & How We Checked

Omega 3's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 49 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Docosahexaenoic Acid (dha) 49 references
  1. Akedo I, Ishikawa H, Nakamura T, et al. Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid (DHA)-concentrated fish oil capsules (abstract). Jpn J Clin Oncol PubMed
  2. Prisco D, Paniccia R, Bandinelli B, et al. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 1998;1:105-12.
  3. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997;66:649-59.
  4. Toft I, Bonaa KH, Ingebretsen OC, et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 1995;123:911-8.
  5. Sacks FM, Hebert P, Appel LJ, et al. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the trials of hypertension prevention. J Hypertens 1994;12:209-13.
  6. Vandongen R, Mori TA, Burke V, et al. Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease. Hypertension 1993;22:371-9. PubMed
  7. FDA. Center for Food Safety and Applied Nutrition. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Available at: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference
  8. Pedersen HS, Mulvad G, Seidelin KN, et al. N-3 fatty acids as a risk factor for haemorrhagic stroke. Lancet 1999;353:812-3. PubMed
  9. Ito Y, Suzuki K, Imai H, et al. Effects of polyunsaturated fatty acids on atrophic gastritis in a Japanese population. Cancer Lett 2001;163:171-8. PubMed
  10. Kris-Ehterton PM, Harris WS, Appel LJ, et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57. PubMed
  11. Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002;76:1007-15.. PubMed
  12. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160:996-8.. PubMed
  13. Leng GC, Smith FB, Fowkes FG, et al. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids 1994;51:101-8. PubMed
  14. Nelson GJ, Schmidt PS, Bartolini GL, et al. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997;32:1129-36. PubMed
  15. Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121:1269-78. PubMed
  16. Malcolm CA, McCulloch DL, Montgomery C, et al. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 2003;88: DOI
  17. Sanjurjo P, Ruiz-Sanz JI, Jimeno P, et al. Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings. J Perinat Med 2004;32:132-6.
  18. Montgomery C, Speake BK, Cameron A, et al. Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 2003;90:135-45. DOI
  19. Lauritzen L, Hoppe C, Straarup EM, Michaelsen KF. Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatr Res 2005;58:235-42. PubMed
  20. Hawkes JS, Bryan DL, Makrides M, et al. A randomized trial of supplementation with docosahexaenoic acid-rich tuna oil and its effects on the human milk cytokines interleukin 1 beta, interleukin 6, and tumor necrosis factor alpha. Am J Clin Nutr 2002;75:75
  21. Uauy R, Hoffman DR, Mena P, et al. Term infant studies of DHA and ARA supplementation on neurodevelopment: Results of randomized controlled trials. J Pediatr 2003;143:S17-25. PubMed
  22. Decsi, T., Campoy, C., and Koletzko, B. Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy: the Nuheal trial. Adv.Exp Med Biol 2005;569:109-113. PubMed
  23. Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., and Beilin, L. J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999;34(2):253-260. PubMed
  24. Otto, S. J., van Houwelingen, A. C., and Hornstra, G. The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Le PubMed
  25. Helland, I. B., Saugstad, O. D., Smith, L., Saarem, K., Solvoll, K., Ganes, T., and Drevon, C. A. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108(5):E82. PubMed
  26. Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., and Raederstorff, D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am.J.Clin.Nutr. 2002;76(2):326-330. PubMed
  27. Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Barden, A., Watts, G. F., and Beilin, L. J. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients PubMed
  28. Jensen, C. L., Voigt, R. G., Prager, T. C., Zou, Y. L., Fraley, J. K., Rozelle, J. C., Turcich, M. R., Llorente, A. M., Anderson, R. E., and Heird, W. C. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed
  29. Theobald, H. E., Goodall, A. H., Sattar, N., Talbot, D. C., Chowienczyk, P. J., and Sanders, T. A. Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 2007;137(4):973-978.
  30. Mischoulon D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18(9):639-645. PubMed
  31. Birch EE, Carlson SE, Hoffman DR, et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexa
  32. Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ. DHA supplementation and pregnancy outcomes. Am J Clin Nutr. 2013 Apr;97(4):808-15. PubMed
  33. Escamilla-Nuñez MC, Barraza-Villarreal A, Hernández-Cadena L, Navarro-Olivos E, Sly PD, Romieu I. Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest. 2014 Aug;146(2):373-82. PubMed
  34. Fu YQ, Zheng JS, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. J Epidemiol. 2015;25(4):261-74. PubMed
  35. Imhoff-Kunsch B, Stein AD, Villalpando S, Martorell R, Ramakrishnan U. Docosahexaenoic acid supplementation from mid-pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. J Nutr. 2011 Feb;141(2): PubMed
  36. Judge MP, Cong X, Harel O, Courville AB, Lammi-Keefe CJ. Maternal consumption of a DHA-containing functional food benefits infant sleep patterning: an early neurodevelopmental measure. Early Hum Dev. 2012 Jul;88(7):531-7. PubMed
  37. Mulder KA, King DJ, Innis SM. Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy. PLoS One. 2014 Jan 10;9(1):e83764. PubMed
  38. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7(9):e43909. PubMed
  39. Drugs in Pregnancy and Lactation 2012;25(4);3-4
  40. FDA announces qualified health claims for omega-3 fatty acids. Available at: https://www.fda.gov/Food/LabelingNutrition/ucm072756.htm. Accessed April 15 2019.
  41. Breastfeeding and the use of human milk. Section on Breastfeeding. Pediatrics. 2012;129(3):e827-41. PubMed
  42. Zhang Z, Fulgoni VL, Kris-Etherton PM, Mitmesser SH. Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001-2014. Nutrients. 2018;10(4). PubMed
  43. Montgomery P, Spreckelsen TF, Burton A, Burton JR, Richardson AJ. Docosahexaenoic acid for reading, working memory and behavior in UK children aged 7-9: A randomized controlled trial for replication (the DOLAB II study). PLoS One. 2018;13(2):e0192909. PubMed
  44. Marc I, Piedboeuf B, Lacaze-Masmonteil T, et al. Effect of maternal docosahexaenoic acid supplementation on bronchopulmonary dysplasia-free survival in breastfed preterm infants: A randomized clinical trial. JAMA. 2020;324(2):157-167. PubMed
  45. Fougère H, Bilodeau JF, Lavoie PM, et al. Docosahexaenoic acid-rich algae oil supplementation on breast milk fatty acid profile of mothers who delivered prematurely: a randomized clinical trial. Sci Rep 2021;11(1):21492. PubMed
  46. Garmendia ML, Casanello P, Flores M, Kusanovic JP, Uauy R. The effects of a combined intervention (docosahexaenoic acid supplementation and home-based dietary counseling) on metabolic control in obese and overweight pregnant women: the MIGHT study. Am J O PubMed
  47. Christifano DN, Gustafson KM, Carlson SE, et al. Maternal docosahexaenoic acid exposure needed to achieve maternal-newborn EQ. Nutrients 2022;14(16):3300. PubMed
  48. Vizzari G, Morniroli D, Alessandretti F, et al. Comparative analysis of docosahexaenoic acid (DHA) content in mother's milk of term and preterm mothers. Nutrients 2022;14(21):4595. PubMed
  49. Yang Y, Li G, Li F, et al. Impact of DHA from algal oil on the breast milk DHA levels of lactating women: A randomized controlled trial in China. Nutrients 2022;14(16):3410. PubMed

See these in context on the Docosahexaenoic Acid (dha) monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Supplement interaction checker › Check any supplement or product against your medications Drug–drug interactions › Check two or more of your medications against each other Browse medications A–Z › Every drug we've checked against herbs & supplements NDC & pricing lookup › Find a drug’s NDCs, packaging and costs Ask a pharmacist › Free, personal answer from our licensed team